Bydureon BCise is a once-weekly injectable medication containing 2 mg of extended-release exenatide, a GLP-1 receptor agonist, designed to improve blood sugar control in individuals with type 2 diabetes mellitus./Description: Bydureon BCise contains extended-release exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist that enhances insulin secretion, suppresses glucagon release, and slows gastric emptying. These actions collectively aid in better blood sugar management for individuals with type 2 diabetes mellitus. The medication is administered once weekly via a prefilled autoinjector pen, providing a convenient and consistent approach to glucose control. Bydureon BCise is suitable for adults and children aged 10 years and above and can be used alone or in combination with other glucose-lowering medications when diet and exercise alone do not suffice.. Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
